For their landmark research that set a foundation for the mRNA SARS-CoV-2 vaccines, Drew Weissman, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, an adjunct professor of neurosurgery at the Perelman School of Medicine and a senior vice president at BioNTech, have been selected to receive the 2021 Albany Prize. The award, one of the largest in medicine and science in the United States, has been given for the last 20 years by Albany Medical Center to those who have altered and positively impacted the course of medical research.
The honor comes after decades of work by Weissman and Karikó, whose scientific findings helped make mRNA vaccines—including the Pfizer/BioNTech SARS-CoV-2 vaccine that recently received full FDA approval—a reality. In 2005, they published research that found how mRNA could be altered in order to use it as a therapeutic. Weissman and Kariko changed the way the mRNA was made by including specific naturally occurring mRNA modifications that make the mRNA safer, more stable, and effective for prophylactic and therapeutic purposes.
“Collectively, The Albany Prize recipients have made major contributions to science over decades as researchers, mentors, and educators,” says Vincent P. Verdile, the Lynne and Mark Groban, MD ’67, Distinguished Dean of Albany Medical College and Chair of The Albany Prize National Selection Committee. “Their years of work, scientific expertise, and sheer determination played a critical role in accelerating the development of two mRNA Covid-19 vaccines. And their dedication exemplifies The Albany Prize legacy to honor scientists whose work has demonstrated significant outcomes for the betterment of humankind.”
This story is by Alex Gardner. Read more at Penn Medicine News.
